
Work Here?
Work Here?
Work Here?
ZBiotics creates genetically engineered probiotic supplements designed to break down acetaldehyde, a toxic byproduct of alcohol consumption. The product is taken as a probiotic pill that works in the gut to neutralize acetaldehyde after drinking, helping reduce hangover symptoms. It is sold directly to consumers via its website, with options for one-time purchases or subscriptions. ZBiotics differentiates itself by a clear, people-first approach and ongoing research into other health challenges (dairy intolerance, radiation exposure, lead contamination in water), alongside a commitment to transparency. The company’s goal is to help people manage the after-effects of alcohol while expanding probiotic science and exploring solutions for other health issues.
Industries
Biotechnology
Healthcare
Consumer Goods
Company Size
51-200
Company Stage
Series A
Total Funding
$14.4M
Headquarters
San Francisco, California
Founded
2016
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$14.4M
Below
Industry Average
Funded Over
3 Rounds
Industry standards
Health Insurance
Dental Insurance
401(k) Company Match
Unlimited Paid Time Off
Parental Leave
Home Office Stipend
Commuter Benefits
Hybrid Work Options
Remote Work Options
ZBiotics floor display wins Silver OMA. OMA Silver Award International partnered with ZBiotics to support its transition from a fast-growing direct-to-consumer brand into brick-and-mortar retail with a bold, modern floor display built to stand out in highly competitive store environments. Program Objective After gaining momentum as a direct-to-consumer brand starting in 2019, ZBiotics identified brick-and-mortar expansion as a strategic priority in early 2024. Entering convenience and liquor channels introduced a clear challenge: winning attention in crowded aisles where space is limited and visual competition is high. The objective was straightforward: create a compact, modern floor display that commands attention while preserving valuable floor space. The solution needed to be... Sources include: Great Northern instore
“When I started ZBiotics, I was sure somebody would beat us to the punch,” says Dr. Zack Abbott, the microbiologist behind a genetically engineered probiotic serving as a hangover remedy that many consumers now swear by. “But when we launched three years later, we were the first to market with a genetically engineered probiotic [ZBiotics Pre-alcohol: a shot containing bacteria engineered to expresses an enzyme that breaks down a toxic byproduct of alcohol in the gut]. “Five years later, we launched our second product [ZBiotics Sugar-to-Fiber: which contains containing bacteria engineered to express an enzyme that converts sugars into fibers in the gut] and still nobody else had launched a GM probiotic. I’m not totally sure why, I think maybe there’s a fear that consumers will reject it, but we just haven’t seen that
Biotechnology company Zbiotics has announced the launch of Sugar-to-Fiber Probiotic Drink Mix, which it claims to be the first product of its kind to hit the consumer market.
ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led
ZBiotics raises $12M in Series A funding.
Find jobs on Simplify and start your career today
Industries
Biotechnology
Healthcare
Consumer Goods
Company Size
51-200
Company Stage
Series A
Total Funding
$14.4M
Headquarters
San Francisco, California
Founded
2016
Find jobs on Simplify and start your career today